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During endochondral bone development, both the chondrogenic differentiation of mesenchyme and the hypertrophic
differentiation of chondrocytes coincide with the proliferative arrest of the differentiating cells. However, the mechanisms
by which differentiation is coordinated with cell cycle withdrawal, and the importance of this coordination for skeletal
development, have not been defined. Through analysis of mice lacking the pRB-related p107 and p130 proteins, we found
that p107 was required in prechondrogenic condensations for cell cycle withdrawal and for quantitatively normal 1(II)
collagen expression. Remarkably, the p107-dependent proliferative arrest of mesenchymal cells was not needed for
qualitative changes that are associated with chondrogenic differentiation, including production of Alcian blue-staining
matrix and expression of the collagen IIB isoform. In chondrocytes, both p107 and p130 contributed to cell cycle exit, and
p107 and p130 loss was accompanied by deregulated proliferation, reduced expression of Cbfa1, and reduced expression of
Cbfa1-dependent genes that are associated with hypertrophic differentiation. Moreover, Cbfa1 was detected, and hypertro-
phic differentiation occurred, only in chondrocytes that had undergone or were undergoing a proliferative arrest. The results
suggest that Cbfa1 links a p107- and p130-mediated cell cycle arrest to chondrocyte terminal differentiation. © 2002 Elsevier
Science (USA)
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Cell differentiation is coordinated with cell cycle with-
drawal in numerous developmental processes. In several
settings, retinoblastoma family proteins are implicated in
coordinating these events. For example, Rb/ mouse em-
bryos exhibited deregulated proliferation together with im-
paired differentiation in hepatic hematopoietic cells, neu-
1 Present address: Department of Biology, Princeton University,
Princeton, NJ 08544.
2 Present address: Department of Biology, Columbia University,
New York, NY 10027.
3 To whom correspondence should be addressed at Columbia
University College of Physicians and Surgeons, Department of
Medicine, 630 W
305-7348. E-mail
0012-1606/02 $35.00
© 2002 Elsevier Scienc
All rights reserved.rons, lens fiber cells, and myoblasts (Lipinski and Jacks,
1999). Similarly, p107/;p130/ embryos exhibited deregu-
lated chondrocyte proliferation and altered hypertrophic
differentiation (Cobrinik et al., 1996). At present, the
mechanisms by which pRB family proteins coordinately
regulate differentiation and cell cycle withdrawal, and the
importance of this coordination for normal development,
are poorly understood. To address these issues, it is neces-
sary to identify differentiation-related events for which pRB
family proteins are required, and to determine whether
such events are linked to cell cycle-dependent or to cell
cycle-independent functions. Taking this approach, the
current study aims to identify differentiation-related events
that require p107 and p130 during endochondral bone
development, and to determine whether such events are
coupled to a p107- and p130-mediated cell cycle arrest.
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Endochondral bone development involves two distinct
differentiation events that coincide with the proliferative
arrest of the differentiating cells. The first of these is the
chondrogenic differentiation of mesenchymal cells. This
process commences when chondrogenic mesenchymal cells
express the Sox9 transcription factor and, under the influ-
ence of Sox9, form tightly packed prechondrogenic conden-
sations (Bi et al., 1999; Hall and Miyake, 1992; Wright et al.,
1995). Cells within these condensations have decreased
proliferation (Hornbruch and Wolpert, 1970; Janners and
Searls, 1970) and express the type IIa collagen mRNA and
type IIA collagen protein isoforms (Lui et al., 1995; Nah and
Upholt, 1991; Ng et al., 1993; Sandell, 1994; Sandell et al.,
1991, 1994). Subsequently cells within the condensations
produce Alcian blue-staining glycosaminoglycans and dif-
ferentiate into chondrocytes (Pizette and Niswander, 2000).
The differentiated chondrocytes are characterized by their
production of a metachromatic matrix, by specific morpho-
logical and ultrastructural features (Wezeman, 1998), and
by their increased expression of 1 (II) collagen mRNA and
collagen II protein (Dessau et al., 1980; Kosher et al., 1986;
Kravis and Upholt, 1985). At the molecular level, chondro-
cytes can be distinguished from chondrogenic mesenchy-
mal cells by their expression of type IIb collagen mRNA
and type IIB collagen protein, as opposed to the type IIA
species (Lui et al., 1995; Nah et al., 2001; Sandell, 1994;
Sandell et al., 1991, 1994). After chondrogenic differentia-
tion, nascent chondrocytes may reenter the cell cycle (our
results, see below). A growth plate is then formed, in which
chondrocytes undergo cell cycle exit and hypertrophic dif-
ferentiation. The resultant hypertrophic chondrocytes are
distinguished by their large size, expression of type X
collagen, and production of mineralized matrix (Horton,
1993).
At present, it is unclear how cell cycle exit is coordinated
with chondrogenic and hypertrophic differentiation. Recent
studies have shown that chondrocyte cell cycle withdrawal
and hypertrophic differentiation are regulated through a
negative feedback system involving Indian hedgehog (Ihh)
and parathyroid hormone-related peptide (PTHrP; reviewed
in Kronenberg and Chung, 2001) and that PTHrP inhibits
both cell cycle withdrawal and hypertrophic differentiation.
However, this does not inform as to how chondrocyte cell
cycle exit and hypertrophic differentiation are normally
coordinated, independent of the PTHrP inhibitory effect. In
addition, Ihh was shown to both promote cell cycle progres-
sion in proliferative zone chondrocytes and to promote
early stages of hypertrophic differentiation, through PTHrP-
independent processes (Karp et al., 2000; St-Jacques et al.,
1999), indicating that Ihh is one of the components that
influences chondrocyte proliferation and differentiation
decisions.
FIG. 1. Patterning of chondrogenic mesenchyme, production of chondrogenic condensations, and 1(II) collagen expression in
p107/p130-deficient embryos. (A, B) Whole-mount in situ hybridization of 11.0-dpc p107/;p130/ (A) and p107/;p130/ (B) embryos
with a Sox9 cRNA probe. The p107/;p130/ and p107/;p130/ embryos have nearly identical expression patterns. (C–F) 12.5-dpc
embryos of the indicated genotypes after staining with Alcian blue. Embryos that were homozygous null for p107 had slightly reduced
staining intensity in some elements, such as the humerus, but had otherwise identical staining patterns. (G–J) Hematoxylin and eosin
staining (G, H) or 1 (II) collagen mRNA in situ hybridization (I, J) of 12.0-dpc p107/;p130/ (G, I) and p107/;p130/ (H, J) embryos,
using sections with the maximum extent of humerus condensation. The p107/;p130/ and p107/;p130/ embryos had similar
crown-to-rump lengths, vascular patterning, eye development, and digital definition (not shown), but p107/;p130/ embryos showed
more obvious chondrocyte morphology and higher 1(II) collagen expression. Bars, 0.1 mm.
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FIG. 2. Proliferation in humerus condensations in p107- and p107/p130-deficient embryos. (A–F) 12.0-dpc and (G–L) 12.5-dpc embryos of
the indicated genotypes were labeled in utero with BrdU, and BrdU-positive nuclei were detected with an anti-BrdU antibody. Arrows point
to humerus condensation. At 12.0 dpc, wild type (A), p107/;p130/ (B), and p107/;p130/ (C) embryos had obvious BrdU-negative
regions corresponding to chondrogenic condensations of the humerus and other elements, whereas p107- and p107/p130-deficient embryos
lacked BrdU-negative zones (D–F). At 12.5 dpc, all humerus primordia had BrdU incorporation, but incorporation increased with loss of
p107 and p130 (see also Table 1). The location of the humerus was confirmed by collagen II immunostaining in nearby sections. (G–L) are
at higher magnification than (A–F).
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Further insight into the coordinate control of chondro-
cyte proliferation and differentiation has come from analy-
ses of mice with mutations in Cbfa1. Cbfa1 encodes a
transcription factor that was initially characterized for its
role in osteoblast differentiation (Ducy et al., 1997; Komori
et al., 1997; Otto et al., 1997; reviewed in Ducy, 2000).
However, Cbfa1 is also required for chondrocyte hypertro-
phic differentiation in humeri and femurs, and for the
normal timing and extent of hypertrophic differentiation in
other skeletal elements (Inada et al., 1999; Kim et al., 1999).
Notably, Cbfa1 was needed for the expression of several
regulators of hypertrophic differentiation, including Ihh
and PTHrP-receptor (PTHrP-R), as well as for expression of
collagen X, which is the predominant collagen gene that is
expressed in hypertrophic cells (Inada et al., 1999; Kim et
al., 1999). Moreover, the expression of Cbfa1 was sufficient
to induce hypertrophic differentiation in elements that do
not otherwise undergo this program (Takeda et al., 2001;
Ueta et al., 2001), suggesting that Cbfa1 expression is rate
limiting for entrance into the hypertrophic differentiation
sequence. During chondrogenesis, Cbfa1 is mainly ex-
pressed in cell populations that have undergone a prolifera-
tive arrest, including cells in prechondrogenic condensa-
tions and in the prehypertrophic and hypertrophic zones of
the growth plate (Ducy et al., 1997; Ferguson et al., 1999;
Inada et al., 1999; Kim et al., 1999). This implies that cell
cycle withdrawal may be important for Cbfa1 expression.
However, Cbfa1 may also contribute to chondrocyte prolif-
erative arrest, since ectopic Cbfa1 inhibited chondrocyte
proliferation in vitro as well as in vivo (Enomoto et al.,
2000; Takeda et al., 2001).
An additional clue to the coordination of chondrocyte
cell cycle exit and differentiation has come from analyses of
mice with p107 and p130 mutations. Combined mutation
of p107 and p130 resulted in grossly abnormal endochondral
bone development in late-gestation embryos, whereas in-
tramembranous bone formation was unaffected (Cobrinik
et al., 1996). p107/;p130/ embryos had deformed growth
plates, with increased chondrocyte proliferation, hypertro-
phic differentiation occurring farther than normal from the
articular surface, and delayed ossification. p107/;p130/
embryos had apparently normal development, implying
that p130 was not limiting in embryos carrying at least one
wild type p107 allele, whereas p107/;p130/ embryos
displayed subtle morphological changes and p107/;
p130/ embryos had an intermediate phenotype. The aber-
rant positioning of hypertrophic chondrocytes in p107/;
p130/ embryos implied that p107 and p130 affect
hypertrophic differentiation, but did not establish whether
p107 and p130 directly participate in this process or are
instead needed for preceding events. Notably, a phenotype
similar to that of p107/;p130/ mutants was elicited by
mutation of p57KIP2, which encodes a Cdk inhibitor that is
highly expressed in chondrocytes, and which is a potential
regulator of p107 and p130 (Yan et al., 1997; Zhang et al.,
1997).
Here, we explore the basis of the abnormal skeletal
development of p107/p130-deficient embryos by examining
the effects of p107 and p130 loss on cell proliferation and
differentiation at several stages of the endochondral se-
quence. The analyses showed that p107 is required for cell
cycle withdrawal during the formation of prechondrogenic
condensations, but that the p107-mediated arrest was not
required for qualitative changes that are associated with
chondrocyte differentiation. The analyses further showed
that a p107- and p130-mediated cell cycle arrest in chon-
drocytes was tightly coupled to Cbfa1 expression and hy-
pertrophic differentiation. The studies thus identify Cbfa1
as a potential intermediary in coordinating p107- and p130-
dependent cell cycle arrest with chondrocyte terminal dif-
ferentiation.
MATERIALS AND METHODS
Mice
p107 and p130 knockout mice were produced and genotyped as
described (Cobrinik et al., 1996; Lee et al., 1996b). The p107()
allele examined in these studies encodes a null allele, with produc-
tion of no detectable p107 protein (Lee et al., 1996b). The p130()
allele inserts an in-frame stop codon in the second exon (Cobrinik
et al., 1996), but may encode a partial p130 protein (J. Rayman, H.
Cam, and B. Dynlacht, personal communication). To generate
embryos of the desired genotypes, matings were conducted be-
tween p107/;p130/ and p107/;p130/ mice or between two
p107/ mice, and were assumed for timing purposes to occur at
midnight.
Skeletal Analyses
Alcian blue staining was performed as described (Jegalian and
DeRobertis, 1992).
In Situ Hybridization
Embryos were fixed in 4% paraformaldehyde overnight. Whole-
mount in situ hybridization was performed by using a digoxigenin-
labeled Sox9 probe (Wright et al., 1995), as described (Ng et al.,
1997). For section in situ hybridization, fixed embryos were em-
bedded in paraffin, sectioned at 7 microns, and probed with
35S-labeled 1(II) collagen (Lee et al., 1996a), Ihh (Bitgood and
McMahon, 1995), or PTH/PTHrP-R (Lee et al., 1995) cRNA, as
described (Lee et al., 1996a).
Immunohistochemistry
Embryos were fixed and sectioned as above, blocked with 4%
horse serum (Sigma) overnight, and incubated overnight with
anti-collagen II (Santa Cruz, sc7764) at 1:500, anti-collagen X
(Jacenko et al., 1993) at 1:2000, anti-p130 (Transduction Laborato-
ries, R27020) at 1:250, anti-Cbfa1 C terminus (Santa Cruz, sc8566)
at 1:500, and anti-Cbfa1 N terminus (A. Geiser, Eli Lilly, Indianap-
olis, IN) at 1:1000. Sections were then washed three times for 5 min
in phosphate-buffered saline (PBS), followed by detection with the
ABC technique and DAB (Vector Laboratories), according to the
manufacturer’s instructions, and counterstained with methyl
green. The two anti-Cbfa1 antibodies gave identical results.
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5-Bromo-2-Deoxyuridine (BrdU) Labeling and
Detection
Embryos were labeled with BrdU by intraperitoneal injection of
pregnant females with 10 mg/ml BrdU, 1.2 mg/ml 5-fluoro-2-
deoxyuridine (Sigma) in PBS at 0.01 ml per gram body weight, 1 h
before sacrifice. Sections prepared as above were incubated with
anti-BrdU antibody (Becton Dickinson), followed by detection
using the ABC kit (Vector Laboratories), and developed with DAB.
Sections were counterstained with methyl green.
Western Analysis
Protein was extracted from 12.5-dpc forelimbs by mixing in
RIPA buffer (150 mM NaCl, 1% Nonidet P-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris, pH 7.5),
followed by sonicating three times for 3 s each. Proteins (200 g)
were separated on an 8% SDS polyacrylamide gel, blotted to PVDF
membranes (Millipore), probed with antibody directed against a
collagen II triple helical domain (Santa Cruz, sc-7764), stripped by
incubating in 62.5 mM Tris (pH 6.8), 100 mM -mercaptoethanol,
2% SDS for 30 min at 70°C, and then reprobed with antibody
directed against collagen IIA-specific sequences (Nah et al., 2001;
generously provided by Dr. H.-Y. Nah, University of Pennsylvania).
Primary antibodies were detected with horseradish peroxidase-
conjugated anti-rabbit or anti-goat antibody (Santa Cruz) and with
LumiGlo chemiluminescent substrate (Kirkegaard and Perry Lab-
oratories), followed by autoradiography. Autoradiographs were
scanned and the signal intensity of each band was normalized to
that of unrelated proteins in each lane of the same immunoblot,
using ImageQuant analysis software.
RESULTS
In order to identify differentiation and proliferation pro-
cesses that are affected by p107 and p130, we analyzed the
major events of endochondral development in embryos of
various p107 and p130 genotypes.
Production of Chondrogenic Mesenchyme and
Prechondrogenic Condensations in p107/p130-
Deficient Embryos
To determine whether p107 and p130 are important for
the production and patterning of chondrogenic mesen-
chyme, we examined the expression of Sox9, which is
specifically expressed in this tissue (Wright et al., 1995).
Expression of Sox9 was indistinguishable in 11.0-dpc
p107/;p130/ and p107/;p130/ embryos (Figs. 1A and
1B) and displayed the distinctive limb expression pattern
that was previously reported for wild type embryos (Wright
et al., 1995). Thus, p107 and p130 were not required for the
production or patterning of chondrogenic mesenchyme.
To evaluate whether the formation of cartilage anlagen
involves p107 and p130, 12.5-dpc embryos were stained
with Alcian blue, which binds to glycosaminoglycans that
are generally produced in cartilage. Embryos of all geno-
types had indistinguishable patterns of Alcian blue stain-
ing, apart from slightly decreased staining intensity in some
elements of p107/;p130/ and p107/;p130/ embryos,
as compared with p107/;p130/ and p107/;p130/ em-
bryos (Figs. 1C–1F). This implies that formation of the
cartilage anlagen, and the production of Alcian blue-
staining matrix within the anlagen, was minimally affected
by p107 and p130 loss.
Although cartilage anlagen formed in a normal pattern in
p107/;p130/ embryos, the p107/;p130/ prechondro-
genic condensations and cartilage anlagen had highly abnor-
mal histology. For example, at 12.0 dpc, p107/;p130/
embryos had well-defined humerus condensations, with the
most central cells having a cobblestone-like organization
(Fig. 1G). In contrast, 107/;p130/ embryos, which were
of a similar developmental stage based on their external
appearance, had clusters of tightly packed and abnormally
small cells in positions where the humerus primordia were
expected to form (Fig. 1H).
Deregulated Proliferation in p107-Deficient and
p107/p130-Deficient Condensations
The increased cell density in prechondrogenic condensa-
tions of p107/p130-deficient embryos suggested that the
proliferation of chondrogenic mesenchymal cells within
the condensations might have been deregulated. To evalu-
ate this, 12.0-dpc embryos were labeled in utero for 1 h with
BrdU, which is incorporated into the DNA of S-phase cells.
Embryo forelimb sections were prepared and BrdU-positive
cells were detected by immunohistochemistry.
As expected, 12.0-dpc wild type, p107/;p130/, and
p107/;p130/ embryos had little if any BrdU incorpora-
tion in the central sections of the humerus, radius, ulna,
and digit condensations (Figs. 2A–2C; and data not shown),
indicative of the cell cycle arrest of the majority of the
chondrogenic mesenchymal cells. Similarly, in 12.0-dpc
Rb/ embryos, the mesenchymal condensations did not
TABLE 1
Chondrocyte Proliferation in 12.5-dpc Humerus Primordia
% BrdU()a
p107/;p130/ 12.3 ( 4.6)
p107/;p130/ 25.9 ( 2.2)
p107/;p130/ 35.4 ( 0.8)
p107/;p130/ 29.0 ( 3.4)
p107/;p130/ 43.9 ( 4.6)
p107/;p130/ 49.0 ( 6.0)
a The percent BrdU-positive cells ( SD) from the center of the
humerus primordia was determined for four sections from two
different 12.5-dpc embryos of each genotype. The positions of the
primordia were ascertained by the presence of cells with a whorled
orientation, representing developing perichondrium, and by colla-
gen II immunostaining in nearby sections. BrdU() and BrdU()
cells were counted within a uniform size region encompassing
approximately half of the cross-sectional area of the condensations.
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incorporate BrdU (data not shown), in keeping with the lack
of Rb expression in chondrogenic mesenchyme (Jiang et al.,
1997). In contrast, BrdU was incorporated throughout the
forelimb condensations of p107/;p130/, p107/;p130/,
and p107/;p130/ embryos (Figs. 2D–2F), indicative of
their aberrantly entering the S-phase of the cell cycle. The
p107/;p130/ cells also aberrantly progressed to mitosis,
since mitotic figures were present throughout p107/;
p130/ condensations but were absent in p107/;p130/
condensations at 12.0 dpc (data not shown). Thus, the loss
of p107 was sufficient to deregulate proliferation within
prechondrogenic condensations, whereas loss of p130 had
little, if any, effect.
We next determined whether chondrogenic mesenchy-
mal cells of p107-deficient and p107/p130-deficient em-
bryos were merely delayed or were entirely defective in cell
cycle exit, by examining BrdU incorporation at 12.5 dpc. At
this age, nascent chondrocytes could be readily identified in
wild type embryos according to morphologic criteria. These
chondrocytes had moderate rates of proliferation (Fig. 2G;
Table 1), showing that the proliferative arrest of chon-
drogenic mesenchymal cells was followed by cell cycle
reentry of differentiated chondrocytes. p107/;p130/ and
p107/;p130/ humeri had significantly increased BrdU in-
corporation relative to wild type humeri (Figs. 2H and 2I;
Table 1; P 0.05 in Student’s t test), indicating that both p107
and p130 affected the rate of proliferation at this time. The
humerus primordia of p107/;p130/, p107/;p130/, and
p107/;p130/ embryos, which had failed to arrest at 12.0
dpc, continued to incorporate BrdU at 12.5 dpc, with incorpo-
ration progressively increasing with loss of the first and
second wild type p130 allele (Figs. 2J–2L; Table 1, P  0.05).
FIG. 3. p130 expression in humerus condensations. Central humerus regions of 12.0 (A, C, E) and 12.5 dpc (B, D, F) wild type (A, B),
p107/;p130/ (C, D), and p107/;p130/ (E, F) embryos were examined for p130 by immunohistochemistry. p130 was not detected in any
embryos at 12.0 dpc, but it was detected in wild type and p107/;p130/ humeri at 12.5 dpc.
FIG. 4. 1(II) collagen expression in humerus condensations of p107- and p107/p130-deficient embryos. 1(II) collagen expression in the
central humerus regions of 12.5-dpc embryos of the indicated genotypes was analyzed by in situ hybridization. Expression was decreased
in the humerus primordia of p107/ embryos (B, E, F), as compared with those with at least one wild type p107 allele (A, C, D). Embryos
in (A) and (B) were littermates and hybridized in parallel. Embryos in (C–F) were from a slightly less advanced litter and were analyzed in
parallel, separate from those in (A) and (B).
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Thus, p107 was required for the transient proliferative arrest
of chondrogenic cells at 12.0 dpc, as well as for maintaining a
normal proliferative rate of chondrocytes at 12.5 dpc. p130
was neither necessary nor sufficient for the proliferative arrest
at 12.0 dpc, but regulated proliferation, together with p107, at
12.5 dpc.
The deregulated proliferation in 12.0-dpc p107/;p130/
condensations implied that p130 was unable to support cell
cycle exit in chondrogenic mesenchymal cells. We thus
evaluated whether the lack of p130-mediated cell cycle
control might relate to a lack of p130 expression. In immu-
nohistochemical analyses of wild type embryos, p130 was
not detected in humerus condensations at 12.0 dpc, but was
detected at 12.5 dpc (Figs. 3A and 3B) and was generally
expressed in chondrocytes at later times (data not shown).
p130 expression did not increase in a compensatory fashion
due to the loss of p107 in either 12.0- or 12.5-dpc
p107/;p130/ embryos (Figs. 3C and 3D). As expected,
p130 was not detected in p107/;p130/ controls (Figs. 3E
and 3F). In contrast to p130, p107 was detected throughout
the mesenchyme and chondrogenic condensations of wild
type embryos at both 12.0 and 12.5 dpc (data not shown).
These findings support the notion that p130 failed to elicit
cell cycle withdrawal in 12.0-dpc p107/;p130/ conden-
sations due to its lack of expression in chondroprogenitor
cells.
Decreased 1 (II) Collagen mRNA, and
Proportionately Decreased Collagen IIA and
Collagen IIB Proteins, in p107-Deficient
Condensations
Because the aberrant proliferation in p107- and p107/
p130-deficient condensations occurred at times when chon-
drogenic mesenchymal cells normally undergo chondro-
genic differentiation, it was of interest to determine
whether p107 and p130 loss was accompanied by a defect in
this differentiation process. At the histologic level, it ap-
peared that chondrogenic differentiation might have been
affected, since cells in the p107- and p107/p130-deficient
condensations were smaller and had a less mature appear-
ance than typical chondrocytes, and failed to produce sig-
nificant amounts of matrix (Figs. 2G–2L). However, p107
and p130 loss was also associated with a qualitatively
normal pattern of Alcian blue staining (Figs. 1C–1F). Since
Alcian blue staining is generally associated with cartilage
(Lev and Spicer, 1964) and occurs as a distinct event in
chondrogenic differentiation (Pizette and Niswander, 2000),
this implied that differentiation into chondrocytes might
not have been impaired.
To evaluate whether p107 and p130 loss affected chon-
drogenic differentiation, we examined whether p107- and
p107/p130-deficient embryos had altered expression of 1
(II) collagen mRNA and collagen II protein, which both
increase during the differentiation process. In situ hybrid-
ization analyses showed that 1 (II) collagen mRNA was
expressed at reduced levels in 12.0-dpc p107/;p130/ vs
p107/;p130/ humerus condensations (Figs. 1I and 1J).
Similarly, 1 (II) collagen was expressed at lower levels
in 12.5-dpc p107- and p107/p130-deficient humerus primor-
dia as compared with those having at least one wild type
p107 allele (Fig. 4). Consistent with the diminished expres-
sion of 1 (II) collagen mRNA, there was decreased colla-
gen II protein in 12.5-dpc p107/;p130/, p107/;p130/,
and p107/;p130/ humeri, as compared with wild type,
p107/;p130/, and p107/;p130/ elements (Figs. 5A–5F).
The diminished 1 (II) collagen mRNA and collagen II
protein in p107-deficient embryos was consistent either
with there being a quantitative decrease in their expression
in chondrocytes, or with there being a qualitative defect in
the differentiation of chondrocytes. To distinguish between
these possibilities, we examined whether p107-deficient
embryos were selectively impaired in their production of
the chondrocyte-specific collagen IIB isoform. To do this,
we compared the production of collagen IIA and collagen IIB
in 12.5-dpc wild type and p107/ embryo forelimbs by
Western analysis.
As expected, two major collagen II species were present in
forelimbs of 12.5-dpc embryos (Figs. 6A, lane 2, and 6B,
lanes 1–4). Of these, the more slowly migrating species was
identified as collagen IIA, by virtue of its being recognized
by a collagen IIA-specific antibody (Fig. 6B, lanes 5–8). The
more rapidly migrating species was identified as collagen
IIB, due to its comigrating with collagen IIB from neonatal
mouse ribs (Fig. 6A, lanes 1 and 2) and due to its not being
recognized by the collagen IIA-specific antibody (Fig. 6B,
lanes 5–8). Consistent with the immunohistochemical
analyses in Fig. 5, p107/ forelimbs had an30% reduction
in collagen IIA and collagen IIB expression (Figs. 6B and 6C).
However, there was a nearly identical ratio of collagen IIB
to collagen IIA in the p107/ and wild type samples (Fig.
6D) indicating that expression of the chondrocyte-specific
collagen IIB isoform was not selectively impaired. Thus,
although p107 was required for cell cycle exit and expres-
sion of quantitatively normal levels of collagen IIA and
collagen IIB, p107 was not required for the transition from
collagen IIA to collagen IIB expression that is indicative of
chondrogenic differentiation.
Impaired Expression of Cbfa1, Ihh, and PTHrP-R
in p107- and p107/p130-Deficient Condensations
After the differentiation of chondroprogenitor cells into
chondrocytes, the nascent chondrocytes may undergo ter-
minal, hypertrophic differentiation. Accordingly, we exam-
ined whether the loss of p107 and p130 affected the expres-
sion of several important regulators of this process. The
analyses focused on the expression of Cbfa1, Ihh, and
PTHrP-R, each of which is normally expressed in chondro-
genic condensations and early chondrocytes (Bitgood and
McMahon, 1995; Ducy et al., 1997; Ferguson et al., 1999;
Karperien et al., 1994; Lee et al., 1995; St-Jacques et al.,
1999).
We initially examined Cbfa1 expression in 12.5-dpc hu-
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merus condensations, by immunohistochemical analysis of
forelimb sections that were adjacent to sections that ex-
pressed collagen II (Fig. 5). Strikingly, whereas Cbfa1 was
readily detected in humerus condensations of wild type,
p107/;p130/, and p107/;p130/ embryos, it was not
detected in p107/p130/, p107/;p130/, and p107/;
p130/ condensations (Figs. 5G–5L). The embryos in which
Cbfa1 was detected at 12.5 dpc carried at least one wild type
p107 allele and were of the same genotypes as those that
had undergone a proliferative arrest at 12.0 dpc. In contrast,
embryos in which Cbfa1 was not detected lacked p107 and
were of genotypes that had deregulated proliferation at
12.0 dpc (Fig. 2). This implied that the expression of Cbfa1
at 12.5 dpc depended on p107 and correlated with the
prior p107-dependent proliferative arrest in prechondro-
genic condensations.
We next determined whether p107 and p130 were re-
quired for Ihh and PTHrP-R expression in 12.5-dpc conden-
sations, using in situ hybridization analysis. Ihh was ex-
pressed throughout the wild type, p107/;p130/, and
p107/;p130/ condensations (Figs. 7A, 7B, and 7D, and
data not shown), but was restricted to a central band of cells
in p107/;p130/, p107/;p130/, and p107/;p130/
elements (Figs. 7C, 7E, and 7F). Thus, as was the case for
Cbfa1, Ihh was predominantly regulated by p107. Interest-
ingly, Ihh was expressed within a larger region of the
condensation in p107/;p130/ humeri as compared with
p107/;p130/ humeri (Figs. 7C and 7F) implying that both
p107 and p130 affect Ihh expression. Loss of p107 and p130
had a similar effect on PTHrP-R, with expression being
greatest for p107/;p130/ and p107/;p130/ embryos
and significantly lower in p107/;p130/, p107/;p130/,
and p107/;p130/ humeri (Figs. 7G–7L).
Thus, the data show that loss of p107 and p130 elicits
reduced expression of three of the important regulators of
the hypertrophic differentiation program.
Delayed Cell Cycle Exit, Cbfa1 Expression, and
Hypertrophic Differentiation in p107- and p107/
p130-Deficient Chondrocytes
Because Cbfa1 was detected only in condensations that
had undergone an earlier arrest, it appeared that Cbfa1
expression might be coordinated with a p107- and p130-
mediated proliferative arrest in chondrocytes. Moreover,
because the expression of Ihh, PTHrP-R, and numerous
other components of the hypertrophic differentiation pro-
gram depends on Cbfa1 (Inada et al., 1999; Kim et al., 1999),
we hypothesized that overt hypertrophic differentiation
might occur only after Cbfa1 was expressed at more normal
levels in p107- and p107/p130-deficient embryos. To evalu-
ate this possibility, we determined whether cell cycle exit,
Cbfa1 expression, and hypertrophic differentiation were
delayed in such embryos at 13.5 dpc, when hypertrophic
differentiation of the humerus first becomes apparent.
As expected, 13.5-dpc wild type, p107/;p130/, and
p107/;p130/ humeri had a well-defined zone of BrdU-
negative and Cbfa1-positive chondrocytes (Figs. 8A–8C and
8F–8H), consistent with the reported expression of Cbfa1
mRNA (Inada et al., 1999; Kim et al., 1999; Takeda et al.,
2001). Importantly, the transition between the BrdU-
positive and -negative regions coincided with the transition
between the Cbfa1-negative and -positive zones. Moreover,
the Cbfa1-positive zone was comprised of collagen X-express-
ing prehypertrophic and hypertrophic cells (Figs. 8K–8M),
in keeping with the role of Cbfa1 in hypertrophic differen-
FIG. 5. Collagen II and Cbfa1 expression in humerus condensa-
tions of p107- and p107/p130-deficient embryos. Adjacent sections
from the central humerus regions of 12.5-dpc embryos, of the
indicated genotypes, were analyzed by immunohistochemistry for
collagen II (A–F) and Cbfa1 (G–L). p107- and p107/p130-deficient
elements had decreased collagen II, but lacked detectable Cbfa1.
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tiation (Inada et al., 1999; Kim et al., 1999). In contrast,
p107/;p130/ humeri had only a small central region
with reduced BrdU incorporation, scant Cbfa1 expression,
and no detectable collagen X or hypertrophic cell morphol-
ogy (Figs. 8D, 8I, and 8N). p107/;p130/ humeri had more
extensive BrdU incorporation and entirely lacked detect-
able Cbfa1 and collagen X throughout the element (Figs. 8E,
8J, and 8O). Thus, at 13.5 dpc, Cbfa1 expression and
hypertrophic differentiation was restricted to regions that
had either undergone or appeared to be undergoing cell
cycle withdrawal, and depended almost entirely on the
presence of p107.
That cell cycle exit and hypertrophic differentiation were
impaired to a similar extent in 13.5-dpc p107/;p130/ and
p107/;p130/ humeri was unexpected, since p107/;
p130/ embryos had far more severely impaired skeletal
development at 18.0 dpc (Cobrinik et al., 1996). Thus, we
evaluated whether p130 contributed to cell cycle exit,
Cbfa1 expression, and hypertrophic differentiation at later
times. At 15.5 dpc, wild type, p107/;p130/, and
p107/;p130/ humeri had well-defined zones of BrdU-
negative and Cbfa1- and collagen X-positive hypertrophic
chondrocytes, as well as a zone of cancellous bone (Figs.
9A–9C, 9F–9H, 9K–9M, and 9P–9R). p107/;p130/ hu-
meri at 15.5 dpc also had a central zone of BrdU-negative
and Cbfa1- and collagen X-positive hypertrophic cells, but
had not initiated bone formation (Figs. 9D, 9I, 9N, and 9S),
consistent with their earlier delay in hypertrophic differen-
tiation. In contrast, p107/;p130/ humeri had only a
small central region with reduced BrdU incorporation, and
low levels of Cbfa1 and collagen X expression on the
periphery of this region (Figs. 9E, 9J, 9O, and 9T). The more
impaired development of p107/;p130/ vs p107/;
p130/ humeri indicated that p130 contributed to cell
cycle exit, Cbfa1 expression, and hypertrophic differentia-
tion of p107-deficient humeri between 13.5 and 15.5 dpc.
In addition to being required for hypertrophic differentia-
tion of the humerus, Cbfa1 promotes hypertrophic differen-
tiation in other elements, such as the radius and phalanges
(Kim et al., 1999). Accordingly, we determined whether
Cbfa1 expression was also limited to nonproliferating
chondrocytes in these elements. In both a 13.5-dpc wild
type radius and a 15.5-dpc p107/;p130/ phalange,
Cbfa1 expression was restricted to a central, BrdU-negative
zone (Figs. 10A–10D). However, Cbfa1 was not detected in
the aberrantly proliferating cells in the corresponding
p107/;p130/ phalange (Figs. 10E and 10F). Thus, Cbfa1
expression was detected only in cartilage regions that had
undergone a proliferative arrest and was impaired, together
with cell cycle exit, in numerous skeletal elements of
p107/p130-deficient embryos.
DISCUSSION
In this study, we have sought to identify differentiation-
related events that require p107 and p130 during endochon-
dral bone development, and to determine whether such
events are linked to p107- and p130-mediated cell cycle
arrest. The analyses showed that p107 and p130 were not
required for the production, patterning, or condensation of
prechondrogenic mesenchyme, or for a number of qualita-
tive changes that mark the transition from chondrogenic
mesenchymal cells to differentiated chondrocytes. How-
ever, p107 was required for cell cycle withdrawal of chon-
drogenic mesenchymal cells and for a quantitatively nor-
mal level of chondrocyte-specific gene expression in
chondrogenic condensations. Further, p130 regulated pro-
liferation in a manner that was partially redundant to p107
in differentiated chondrocytes, and the deregulated prolif-
eration in p107- and p107/p130-deficient chondrocytes was
accompanied by delayed Cbfa1 expression as well as de-
layed hypertrophic differentiation. Because of the well-
established role of Cbfa1 in hypertrophic differentiation,
the results suggest that Cbfa1 mediates the major effects of
p107 and p130 on skeletal development.
Regulation of Chondroprogenitor Cell Proliferation
and Quantitative Aspects of Chondrocyte
Differentiation by p107
A striking and unexpected finding from the current work
was that p107 has a critical role in regulating chondropro-
genitor cell proliferation. Earlier analyses had shown that
18.0-dpc p107/ embryos had only subtle skeletal changes,
whereas p107/;p130/ embryos displayed a severe chon-
drodysplasia (Cobrinik et al., 1996). From this, it was
surmised that the loss of p107 might also have only subtle
consequences at the cellular level, due to the redundant
functioning of p130. However, the studies described here,
showed that p107 loss dramatically increased proliferation
in 12.0-dpc prechondrogenic condensations, regardless of
the p130 genotype (Fig. 2). p130 failed to compensate for
p107 loss, potentially due to its insufficient expression in
chondroprogenitor cells.
Because the deregulated proliferation of p107-deficient
chondroprogenitor cells occurred at times when chondro-
genic differentiation normally takes place, it was antici-
pated that the loss of p107 might be associated with
defective chondrogenic differentiation. Indeed, the deregu-
lated proliferation was associated with abnormal chondro-
cyte behavior, manifested by a less mature histologic
appearance and decreased 1 (II) collagen expression. How-
ever, the aberrant proliferation of the p107-deficient chon-
droprogenitor cells did not prevent several qualitative
changes that are associated with chondrogenic differentia-
tion. For example, p107-deficient as well as p107/p130-
deficient embryos formed Alcian blue-staining cartilage
primordia with normal timing and in a normal pattern,
albeit with slightly reduced staining intensity (Fig. 1). More
significantly, the decline in collagen II expression in 12.5-
dpc p107-deficient embryos affected the collagen IIA and
collagen IIB isoforms to a similar extent (Fig. 6). Since the
vast majority of type IIb collagen mRNA is expressed in
279Chondrocyte Proliferation and Differentiation Control
© 2002 Elsevier Science (USA). All rights reserved.
chondrocytes (Sandell, 1994; Sandell et al., 1991, 1994), this
suggests that deregulated proliferation in p107-deficient
condensations did not impair the transition of collagen
IIA-expressing chondroprogenitor cells to collagen IIB-
expressing chondrocytes.
Coordinate Control of Cell Cycle Exit and Cbfa1
Expression by p107 and p130
In addition to the modest quantitative effect of p107 and
p130 loss on the expression of collagen II, the loss of
p107 and p130 impaired the expression of Cbfa1. At 12.5
dpc, Cbfa1 was expressed throughout the humerus conden-
sations of wild type, p107/;p130/, and p107/;p130/
embryos, which are genotypes in which prechondrogenic
condensations had undergone cell cycle exit. In con-
trast, Cbfa1 was not detected in the condensations of
p107/;p130/, p107/;p130/, or p107/;p130/ em-
bryos, which are genotypes in which such condensations
had failed to exit the cell cycle. That Cbfa1 was detected
only in condensations that had undergone an earlier prolif-
erative arrest suggests that the normal levels of Cbfa1
expression may depend on the earlier cell cycle exit. This
view is further supported by the finding that Cbfa1 mRNA
is highly expressed in early chondrogenic condensations but
is diminished after chondrocyte differentiation (Ducy et al.,
1997; Ferguson et al., 1999) and presumably after reentry of
nascent chondrocytes into the cell cycle. In consonance
with the linkage between Cbfa1 expression and cell cycle
withdrawal in chondrogenic condensations, Cbfa1 was de-
tected only in the growth plate regions in which chondro-
cytes were arrested or appeared to be undergoing a prolif-
erative arrest.
While the current findings demonstrate that p107 and
p130 coordinately promote cell cycle exit and Cbfa1 expres-
sion, the precise relationship between these effects remains
unclear. As one possibility, p107 and p130 might indirectly
promote Cbfa1 expression by inducing cell cycle exit.
However, cell cycle arrest apparently was not sufficient for
normal Cbfa1 expression, since Cbfa1 was detected in only
a subset of cells within a BrdU-negative region in 15.5-dpc
p107/;p130/ embryos (Figs. 9J and 9O). Whether this
reflects that p107 and p130 promote Cbfa1 expression
through a cell cycle-independent mechanism, or merely
reflects the highly aberrant cartilage development of this
genotype, remains to be determined. Notably, in p107/;
p130/ humeri, Cbfa1 was expressed in a small central
region that had diminished BrdU incorporation at 13.5 dpc
(Figs. 8D and 8I) and at an irregularly shaped transition
between BrdU-positive and -negative zones at 15.5 dpc
(Figs. 9I and 9N). That Cbfa1 was expressed in such close
proximity to BrdU-positive cells in this genotype suggests
that Cbfa1 expression may not only depend on diminished
proliferation, but may also promote cell cycle exit, in
keeping with its recognized potential for doing so (Enomoto
et al., 2000; Takeda et al., 2001).
Interestingly, although cell cycle exit and Cbfa1 expres-
FIG. 6. Expression of collagen IIA and collagen IIB in p107-deficient
forelimbs. (A) Western analysis of proteins from wild type neonatal
ribs (lane 1), or 12.5-dpc forelimbs (lane 2), probed with an antibody
that recognizes both collagen IIA and collagen IIB. (B) Western
analysis of proteins from wild type (lanes 1, 3, 5, 7) or p107/ (lanes 2,
4, 6, 8) embryos, probed with an antibody that recognizes both
collagen IIA and collagen IIB (lanes 1–4), and then reprobed with an
antibody that is specific for collagen IIA (lanes 5–8) and with anti-
tubulin (not shown). (C) Relative collagen IIA and collagen IIB expres-
sion in p107/ and p107/ forelimbs, after quantitation by densito-
metric scanning of lanes 1–4 in (B), as described in Materials and
Methods. (D) Ratio of collagen IIB:collagen IIA expression in p107/
and p107/ forelimbs. Values in (C) and (D) represent averages for two
embryos of each genotype, and error bars indicate standard deviations.
FIG. 7. Ihh and PTHrP-R expression in humerus condensations of
p107- and p107/p130-deficient embryos. In situ hybridization of
Ihh (A–F) and PTHrP-R (G–L) in 12.5-dpc humeri of the indicated
genotypes. (A–C, D–F, G–I, and J–L) Independent hybridization
experiments, respectively. Ihh was expressed throughout elements
having at least one wild type p107 allele (A, B, D), but expression
was limited to the central region of p107- and p107/p130-deficient
elements (C, E, F). PTHrP-R was expressed at highest levels in
embryos with at least one wild type p107 allele (G, J).
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sion were regulated by both p107 and p130 after 13.5 dpc,
p107 and p130 were not absolutely required for cell cycle
arrest, Cbfa1 expression, or hypertrophic differentiation.
Indeed, chondrocytes eventually underwent each of these
processes in p107/;p130/ cartilage, both in our knockout
strains and in p107/;p130/ embryos that carried distinct
p107 and p130 knockout alleles (F.R. and D.C., unpublished
observations; alleles described in Dannenberg et al., 2000;
Robanus-Maandag et al., 1998). This suggests the existence
of redundant mechanisms to inhibit chondrocyte prolifera-
tion, potentially involving pRB.
Significance of Cbfa1 Regulation by p107 and p130
An important issue that is raised by the current observa-
tions is whether p107 and p130 promote hypertrophic
differentiation primarily through their effects on Cbfa1. In
support of this notion, Cbfa1 is expressed very early during
chondrocyte differentiation and is important for the expres-
sion of most, if not all, components of the hypertrophic
differentiation program. Indeed, Cbfa1 expression coin-
cided with that of Ihh in the humerus anlagen as early as
12.0 dpc (Ferguson et al., 1999). This early Cbfa1 expression
seems likely to be required for the early expression of Ihh,
since Cbfa1/ humeri lacked Ihh mRNA from the earliest
time point (13.5 dpc) that was examined (Inada et al., 1999;
Kim et al., 1999). Cbfa1/ humeri also had diminished
expression of other genes that are specific to prehypertro-
phic and hypertrophic chondrocytes, including PTHrP-R,
BMP6, and type X collagen (Inada et al., 1999). On this
basis, the diminished Cbfa1 expression may account for the
decreased expression of Ihh and PTHrP-R, as well as other
aspects of the delayed hypertrophic program, in p107/p130-
deficient embryos. Notably, whereas the genetic data pre-
dict that the elimination of Cbfa1 would result in the
absence of Ihh expression, the 12.5-dpc p107/;p130/
humeri had detectable Ihh mRNA (Fig. 7). This suggests
that the p107/;p130/ elements may have a low level of
Cbfa1, which permits Ihh to be expressed.
Although delayed Cbfa1 expression would be expected to
give rise to the delayed hypertrophic differentiation in
p107/;p130/ humeri, it is important to consider whether
this phenotype might have been elicited by a general
differentiation delay, as opposed to a specific deficit in
Cbfa1. Indeed, the diminished expression of collagen II and
the slightly reduced Alcian blue staining intensity of p107-
deficient embryos suggests that there were quantitative
gene expression changes during early chondrogenesis that
may be relevant to the diminished Cbfa1 as well as to other
aspects of the mutant phenotype. However, our data sug-
gest that the delay in differentiation is not a general one,
since p107-deficient embryos had a normal collagen IIB:
collagen IIA ratio. Moreover, it is notable that Cbfa1 can
induce the entire hypertrophic differentiation program
when ectopically expressed in chondrocytes that do not
normally undergo this process (Takeda et al., 2001). This
suggests that Cbfa1 expression is not solely a component of
a larger hypertrophic differentiation program that is delayed
in p107/p130-deficient humeri, but is the defining event
that is required for humerus chondrocytes to enter the
hypertrophic sequence.
From the above considerations, we suggest that the delayed
hypertrophic differentiation in p107- and p107/p130-defi-
cient embryos most likely resulted from the reduced ex-
pression of Cbfa1 in the aberrantly proliferating chondro-
cytes. Indeed, the phenotype of such embryos is consistent
with that which would be predicted if the loss of p107 and
p130 elicited a substantial but incomplete reduction in
Cbfa1 expression, followed by more normal Cbfa1 expres-
sion upon cell cycle withdrawal. However, at this time, it
cannot be excluded that there may be other relevant effects
of p107 and p130 loss, and confirmation of the central
importance of Cbfa1 may require a genetic test to deter-
FIG. 10. Cbfa1 expression in BrdU-negative regions of other skeletal elements of p107- and p107/p130-deficient embryos. Embryos of the
indicated genotypes were labeled in utero with BrdU, and adjacent sections of a 13.5-dpc radius (A, B) or 15.5-dpc phalanges (C–F) were
analyzed for BrdU (A, C, E) or Cbfa1 (B, D, F). Cbfa1 was expressed in the BrdU-negative zone of the wild type radius (A, B) and in the
p107/;p130/ phalange (C, D), but not in the aberrantly proliferating p107/;p130/ phalange (E, F).
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mine whether ectopic Cbfa1 production restores more nor-
mal hypertrophic differentiation to p107/;p130/ humeri.
In summary, the data presented in this study suggest that
Cbfa1 mediates the major effects of p107 and p130 on
chondrocyte terminal differentiation. Notably, whereas
p107 and p130 apparently regulate Cbfa1 expression in
chondrocytes, pRB has been shown to regulate the tran-
scriptional activating ability of Cbfa1 in osteoblasts
(Thomas et al., 2001). Thus, Cbfa1 may link pRB family
proteins to two distinct cell differentiation programs during
skeletal development.
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